Pharmafile Logo
Pharmafocus logo
Advanced Search

UK

Showing 15 posts of 472 posts found.

mental-health-3332122_960_720

Mental health spending varies dramatically among regions in England, analysis shows

May 14, 2019
Manufacturing and Production England, NHS, UK, mental health, mind, spending

Spending on mental health varies dramatically between regions in England, according to analysis from mental health charity Mind. South Yorkshire …

News
shutterstock_87495637

UK GPs are underequipped to handle growing chronic opioid use, report warns

May 13, 2019
Medical Communications, Sales and Marketing NHS, UK, opioid crisis, opioids, pharma

New research from the University of East Anglia (UEA) has argued that general practitioners (GPs) in the UK are lacking …

News

Heart disease deaths increase for first time in 50 years

May 13, 2019
Sales and Marketing BHF, UK, cardiovascular, health, heart disease, obesity

Deaths from heart disease among people under the age of 75 have increased for the first time in 50 years. …

News
genentech_web

Ocrevus becomes first NICE-approved therapy on the NHS for primary progressive multiple sclerosis

May 9, 2019
Sales and Marketing Genentech, NHS, NICE, Ocrevus, UK

NICE has announced its final appraisal decision on Genentech’s Ocrevus (ocrelizumab), choosing to recommend the drug for use on the …

News

US prescription drugs most expensive in world, analysis shows

May 8, 2019
Research and Development Drug pricing, Japan, Ontario, UK, US, prescription drugs

Brand name prescription drugs cost on average 4.3 times more in the United States than in the UK, according to …

News

Will mobile phones save the NHS?

May 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, feature, mhealth, mobile health, pharma

The NHS is sick. According to politicians and NHS chiefs, the cure involves a strong dose of mHealth. Louis Goss …

Feature

Two thirds of MPs believe NHS should spend less on medicines

April 30, 2019
Manufacturing and Production Long Term Plan, MPs, NHS, UK, government, health, public health

Nearly two thirds (64%) of MPs believe the NHS should direct more resources towards prevention, over funding for new treatments, …

News

The price of access: Can the NHS afford Orkambi?

April 29, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, NHS, NICE, Orkambi, UK, Vertex, access, cystic fibrosis, feature, pharma, pricing

The impasse over access to Vertex’s Orkambi for cystic fibrosis patients in England and Wales has revealed the cracks in …

Feature

NICE recommends UCB’s Cimzia in severe plaque psoriasis

April 18, 2019
Sales and Marketing Cimzia, NICE, UCB Pharma, UK, pharma, plaque psoriasis, psoriasis

NICE has announced its decision to recommend UCB Pharma’s Cimzia (certolizumab pegol) for use on the NHS in England in …

News

NICE recommends Akcea’s Tegsedi for rare, life-threatening progressive disease

April 17, 2019
Research and Development, Sales and Marketing Akcea, NHS, NICE, Tegsedi, UK

Akcea Therapeutics has shared the news that Tegsedi (inotersen), its antisense oligonucleotide (ASO) inhibitor of human transthyretin (TTR) production, has …

News
28246711066_52e38bc591_z

NHS Confederation chief says news of Brexit extension is a relief

April 12, 2019
EU, NHS, UK, brexit, health, medicine

Niall Dickson, the Chief Executive of the NHS Confederation, has said news of the decision to extend the Brexit deadline …

News
1468995876_rb-centre-for-scientific-excellence

Reckitt Benckiser to unveil £105 R&D site in Hull by end of June

April 11, 2019
Manufacturing and Production Hull, R&D, Reckitt Benckiser, UK, pharma

Reckitt Benckiser (RB) has announced that its £105 million research and development facility in the UK city of Hull – …

News
shutterstock_57369385

Epilepsy Society calls for review of UK supply chain following “steep rise” in access issues

April 9, 2019
Manufacturing and Production, Sales and Marketing Epilepsy Society, UK, brexit, epilepsy, market access, pharma

The Epilepsy Society has drawn attention to the “steep rise” in UK patients who are encountering difficulty in accessing seizure …

News

Eisai and MSD’s Lenvima recommended for NHS Scotland in advanced or unresectable liver cancer

April 8, 2019
Manufacturing and Production, Sales and Marketing Cancer, NHS, Scotland, Scottish Medicines Consortium, UK, liver cancer, pharma

Patients in Scotland with with advanced or unresectable hepatocellular carcinoma (HCC) will now be able to access Eisai and MSD’s …

News

NICE turns down Astellas’ Xtandi in prostate cancer

April 8, 2019
Research and Development, Sales and Marketing Astellas, Cancer, NHS, NICE, UK, pharma, prostate cancer

Astellas’ Xtandi (enzalutamide) has been rejected by UK medicines watchdog NICE for use on the NHS as a therapy for …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026